Department of Biostatistics and Medical Informatics, Medical Faculty, Erzincan Binali Yıldırım University, 24100-Erzincan, Turkey.
Department of Biochemistry, Faculty of Medicine, Van Yuzuncu Yıl University, 65080-Van, Turkey.
Int Immunopharmacol. 2021 Nov;100:108127. doi: 10.1016/j.intimp.2021.108127. Epub 2021 Sep 9.
Early detection of oxidant-antioxidant levels and special care in severe patients are important in combating the COVID-19 epidemic. However, this process is costly and time consuming. Therefore, there is a need for faster, reliable and economical methods.
In this study, antioxidant/oxidant levels of patients were estimated by Expert-models using biomarkers, which are effective in the diagnosis/prognosis of COVID-19 disease. For this purpose, Expert-models were trained and created between the white-blood-cell-count (WBC), lymphocyte-count (LYM), C-reactive-protein (CRP), D-dimer, ferritin values of 35 patients with COVID-19 and antioxidant/oxidant parameter values of the same patients. Error criteria and R ratio were taken into account for the performance of the models. The validity of the all models was checked by the Box-Jenkis-method.
Antioxidant/Oxidant levels were estimated with 95% confidence-coefficient using the values of WBC, LYM, CRP, D-dimer, ferritin of different 500 patients diagnosed with COVID-19 with the trained models. The error rate of all models was low and the coefficients of determination were sufficient. In the first data set, there was no significant difference between measured antioxidant/oxidant levels and predicted antioxidant/oxidant levels. This result showed that the models are accurate and reliable. In determining antioxidant/oxidant levels, LYM and ferritin biomarkers had the most effect on models, while WBC and CRP biomarkers had the least effect. The antioxidant/oxidant parameter estimated with the highest accuracy was Native-Thiol divided by Total-Thiol.
The results showed that the antioxidant/oxidant levels of infected patients can be estimated accurately and reliably with LYM, ferritin, D-dimer, WBC, CRP biomarkers in the COVID-19 outbreak.
在抗击 COVID-19 疫情中,早期检测氧化还原水平和对重症患者的特殊护理非常重要。然而,这个过程既昂贵又耗时。因此,需要更快、更可靠和更经济的方法。
在这项研究中,使用专家模型通过生物标志物来估计患者的抗氧化/氧化水平,这些生物标志物对 COVID-19 疾病的诊断/预后有效。为此,在 35 名 COVID-19 患者的白细胞计数(WBC)、淋巴细胞计数(LYM)、C 反应蛋白(CRP)、D-二聚体、铁蛋白值与相同患者的抗氧化/氧化参数值之间训练和创建了专家模型。考虑了误差标准和 R 比来评估模型的性能。通过 Box-Jenkis 方法检查所有模型的有效性。
使用不同的 500 名诊断为 COVID-19 的患者的 WBC、LYM、CRP、D-二聚体、铁蛋白值,使用训练好的模型以 95%置信系数估计了抗氧化/氧化水平。所有模型的错误率都较低,决定系数也足够。在第一个数据集,实测抗氧化/氧化水平与预测抗氧化/氧化水平之间没有显著差异。这一结果表明模型是准确和可靠的。在确定抗氧化/氧化水平时,LYM 和铁蛋白生物标志物对模型的影响最大,而 WBC 和 CRP 生物标志物的影响最小。用最高精度估计的抗氧化/氧化参数是 Native-Thiol 除以 Total-Thiol。
结果表明,在 COVID-19 爆发期间,可以使用 LYM、铁蛋白、D-二聚体、WBC、CRP 生物标志物准确可靠地估计感染患者的抗氧化/氧化水平。